Reckitt Benckiser plans to demerge its pharmaceuticals arm, while GlaxoSmithKline has raised the possibility of spinning off its healthcare arm. Lex's Alan Livsey and Oliver Ralph discuss whether healthcare and pharma still make good stablemates.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
